Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rosetta microRNA-based test earns DOH approval
The test identifies the primary origin of many types of tumors of uncertain or unknown origin and facilitates physicians by confirming suspected origins, or providing possible new origins
The test identifies the primary origin of many types of tumors of uncertain or unknown origin and facilitates physicians by confirming suspected origins, or providing possible new origins
According to the company, MyPRS Plus helps gain further insights of individual’s genetic characteristics and also determines the molecular sub-group to which each patient belongs. The relapse and
The drug is indicated in conjunction with a mildly hypocaloric diet for the treatments of obese patients with associated risk factors. Teva Commercial Director Kim Innes said they
Arhalofenate is a uricosuric agent, when used in combination with xanthine oxidase inhibitors could be a treatment option for patients with tophaceous gout, a chronic, progressive rheumatic disease.
Under the agreement Menarini’s OTC Division is granted exclusive rights to market and sell Emtrix under the trademark YouDerm Emtrix. Moberg Derma president and CEO Peter Wolpert said
SB12 is an oral care agent for bad breath. Meda has established SB12 in the Nordic region. In 2012, Meda intends to launch SB12 in about ten markets
The product comprises a blend of various ingredients including orange pekoe extract, green tea extract, black tea extract, hibiscus flower powder and Malva sylvestris extract. According to the
Under the agreement, the company will provide community oncology practices with better access to oral oncology drugs, clinical programs and adherence-enhancing medication management programs. RainTree Oncology president and
Under the collaboration, the combination of Merck’s proprietary RSV antigen will be evaluated with NanoBio’s NanoStat adjuvant technology, for use as an intranasal vaccine. As per the deal,
The new prostate formula is developed using the Nature’s Bioceuticals’ kidney formula as a base and adding a number of additional natural ingredients which target the prostate gland.